Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000886744-17-000017
Filing Date
2017-03-31
Accepted
2017-03-31 19:28:32
Documents
1
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3324
  Complete submission text file 0000886744-17-000017.txt   4831
Mailing Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025 6504737700
GERON CORP (Issuer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CALITHERA BIOSCIENCES, INC. 343 OYSTER POINT BLVD., SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address
Molineaux Susan (Reporting) CIK: 0001553389 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-20859 | Film No.: 17731894